Magnetic Resonance Imaging (MRI) News and Research

RSS

Magnetic resonance imaging (MRI) uses a large magnet and radio waves to look at organs and structures inside your body. Health care professionals use MRI scans to diagnose a variety of conditions, from torn ligaments to tumors. MRIs are very useful for examining the brain and spinal cord. Also called: Magnetic resonance imaging, NMR, Nuclear magnetic resonance.

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

With this approval, RINVOQ® is the first and only Janus Kinase inhibitor approved to treat patients across the spectrum of axial spondyloarthritis (nr-axSpA and ankylosing spondylitis) in the EU.

From AbbVie 29 Jul 2022

How COVID-19 affects the brain microvasculature

A recent study discusses the effects of COVID-19 on the brain microvascular system.

25 Jul 2022

Low risk of myocarditis recurrence after COVID-19 mRNA vaccination

A new study investigated the safety profile of COVID-19 mRNA vaccines in individuals with a history of myocarditis.

20 Jul 2022

Racial discrimination may affect brain matter integrity through the stress system

Racial discrimination increases the risk for physical and mental illnesses, and Black women suffer from diseases at significantly higher rates than White women.

20 Jul 2022

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Scientists have published a new review focusing on the relationship between PD and gut microbiota.

15 Jul 2022

Mild to moderate COVID causes inflammation of white matter in brain ten months later

In a recent work published in the medRxiv* preprint server, scientists in Germany performed neuropsychological evaluations and brain imaging of people who recovered from mild to moderate coronavirus disease 2019 (COVID-19).

12 Jul 2022

Impaired cardiac metabolism linked to increased risk of fatal arrhythmias or sudden cardiac death

Adults with abnormal heart metabolism are up to three times more likely to experience life-threatening arrhythmias (an irregular heart rhythm), and MRI techniques could be used to detect the condition and predict future sudden cardiac death (SCD), according to a small, but rigorous study led by Johns Hopkins Medicine researchers.

11 Jul 2022

COVID-19 and brain damage explained

In a recent study published in the Brain journal, researchers in the United States analyzed the neurovascular injury in coronavirus disease 2019 (COVID-19).

7 Jul 2022

New K+-sensitive dual-mode imaging probe for diagnosis of tumor malignancy

Tumor malignancy identification plays an essential role in clinical management of cancer. Currently, biopsy is the gold standard for malignancy identification in most tumor cases, it is, however, invasive that can cause great discomfort to patients, and potentially increase the risk of distant metastases due to the complex sampling process.

1 Jul 2022

Neural effects of COVID-19 on depressive symptoms

A new study identifies brain abnormalities in patients who recovered from COVID-19.

28 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

AbbVie today announced the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) recommended the approval of upadacitinib (RINVOQ® 15 mg, once daily) for the treatment of active non-radiographic axial spondyloarthritis (nr‑axSpA) in adult patients with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI), who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs).*

27 Jun 2022

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

27 Jun 2022

Brain tumor classification can become more accurate with the use of artificial intelligence and physiological imaging

The classification of brain tumors – and thus the choice of optimal treatment options – can become more accurate and precise through the use of artificial intelligence in combination with physiological imaging.

22 Jun 2022

Simplicity is key when it comes to ablation, global AFib study finds

Results from one of the largest global studies of atrial fibrillation (AFib) procedures show that the simple approach is usually best when it comes to ablation, a procedure where physicians destroy or ablate cardiac tissue to correct irregular heart rhythms.

21 Jun 2022

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

A new study reported four cases of Myelin Oligodendrocyte Glycoprotein-Associated Disorder that commenced after SARS-CoV-2 infection.

21 Jun 2022

MRI-based machine learning approach can accurately predict Alzheimer’s disease

The research uses machine learning technology to look at structural features within the brain, including in regions not previously associated with Alzheimer's.

20 Jun 2022

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

Albert Einstein College of Medicine researchers have been awarded a five-year, $3.5 million grant from the National Institutes of Health to study the effects of COVID-19 on the brains of adults who had mild or asymptomatic infection.

8 Jun 2022

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

The National Institute on Aging, a division of the National Institutes of Health, awarded Berislav Zlokovic, MD, PhD, director of the Zilkha Neurogenetic Institute, and Arthur W. Toga, PhD, director of the USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), $16.1 million to continue research on the role that blood vessel dysfunction plays in the development of dementia and Alzheimer's disease.

7 Jun 2022

Profound neuroinflammation associated with long COVID

Around 36 to 53% of coronavirus disease 2019 (COVID-19) patients develop persistent chronic symptoms, often referred to as long COVID or PASC.

7 Jun 2022

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

A new study utilizes multisystem imaging, along with biomarker analysis, to better understand the pathogenesis of COVID-19.

30 May 2022

Magnetic Resonance Imaging (MRI) News and Research

Further Reading

RINVOQ® (upadacitinib) Approved by European Commission as an Oral Treatment for Adults with Active Non-Radiographic Axial Spondyloarthritis

How COVID-19 affects the brain microvasculature

Low risk of myocarditis recurrence after COVID-19 mRNA vaccination

Racial discrimination may affect brain matter integrity through the stress system

Exploring the connection between Parkinson's disease and gut microbiota to uncover potential therapeutic targets

Mild to moderate COVID causes inflammation of white matter in brain ten months later

Impaired cardiac metabolism linked to increased risk of fatal arrhythmias or sudden cardiac death

COVID-19 and brain damage explained

New K+-sensitive dual-mode imaging probe for diagnosis of tumor malignancy

Neural effects of COVID-19 on depressive symptoms

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

CHMP recommends approval of upadacitinib (RINVOQ®) for the treatment of adults with active non-radiographic axial spondyloarthritis

Brain tumor classification can become more accurate with the use of artificial intelligence and physiological imaging

Simplicity is key when it comes to ablation, global AFib study finds

SARS-CoV-2 infection may be a trigger of myelin oligodendrocyte glycoprotein-associated disorder

MRI-based machine learning approach can accurately predict Alzheimer’s disease

Einstein researchers receive $3.5 million NIH grant to study the effects of SARS-CoV-2 on the brain

USC scientists receive more than $16 million to study the role of blood vessel dysfunction in Alzheimer’s disease

Profound neuroinflammation associated with long COVID

Scientists determine trajectory and pathophysiology of post-COVID-19 syndrome

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News